CDER New April 6, 2020

Updated Monday through Friday

• Drug Firm Annual Registration Status
• Drug Firm Annual Registration Status Download File 
• National Drug Code Directory
• NDC Unfinished Drugs Excluded Database File 
• NDC Database Excluded Packages and Products 
• Wholesale Distributor and Third-Party Logistics Providers Reporting  

April 3, 2020

• Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the FD&C Act
• FDA Drug Shortages
  • Dicyclomine Oral Tablets/Capsules (Updated - Currently in Shortage)
  • Dobutamine Hydrochloride Injection (Updated - Currently in Shortage)
  • Dobutamine Hydrochloride Injection (New - Discontinuation)
  • Hydroxychloroquine Sulfate Tablets (Updated - Currently in Shortage)
  • Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
  • Levetiracetam Immediate-Release Oral Tablets, USP (Updated - Currently in Shortage)
  • Nalbuphine Hydrochloride Injection (Updated - Currently in Shortage)
  • Ranitidine Injection, USP (Updated - Discontinuation)
  • Ranitidine Tablets/Capsules (Updated - Discontinuation)
  • Tacrolimus Capsules (Updated - Currently in Shortage)
  • Ketorolac Tromethamine Injection (New - Currently in Shortage)
  • Sumatriptan Succinate (Imitrex) Injection (New - Discontinuation)
  • Testosterone Topical Gel (New - Discontinuation)